Doravirine/Islatravir (100mg/0.75mg) once daily compared to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as Initial HIV-1 treatment: 48 week results from a double-blind phase 3 trial

J. K. Rockstroh, R. Paredes,P. Cahn,J. -M. Molina, S. Sokhela,F. Hinestrosa, S. Kassim, E. Valencia Ortega, D. Cunningham, J. Ghosn, J. R. Bogner,H. Gatanaga,E. Asante-Appiah, Y. Zang,S. O. Klopfer,K. Eves, M. L. Pisculli, K. Squires, T. A. Correll

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY（2023）

Cited 0|Views1

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined